Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Teens with PCOS: could Myo-Inositol fix your cycle?

NCT ID NCT06800170

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 5 times

Summary

This study tests whether two natural supplements, myo-Inositol and Dioscorea Villosa, can help teenagers aged 14-19 with irregular menstrual cycles, including those with PCOS. The goal is to see if these supplements can make periods more regular. The trial is small, with only 20 participants, and is currently recruiting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
myo-Inositol and Dioscorea Villosa (dietary supplements)
What this could lead to
If it works, this could offer a natural supplement option to help teens with PCOS or irregular periods have more regular cycles.
What could go wrong
This is a very small early trial with only 20 participants, so results may not apply widely. Supplements may not work for everyone and could have side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

41 people

The number who actually took part.

Started

Jun 2025

Finished

Jun 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

14 to 19 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * adolescent women aged 14-19 years old, with at least 3 years passed after menarche, and oligomenorrhea or amenorrhea Exclusion Criteria: * Primary amenorrhea. * Hyperandrogenism due to other factors (i.e. adrenal hyperplasia or Cushing syndrome). * Hyperprolactinemia or overt hypothyroidism (TSH ≥4). * Other hormonal alterations. * Ongoing hormonal therapies, including OCPs, six months before enrollment. * Ongoing pharmacological therapies. * Ongoing use of myo-Inositol supplement or other source of myo-Inositol, or Dioscorea villosa, six months before enrollment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Amenorrhea are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Obstetrics and Gynecology with Reproductive Medicine, F.I. Inozemtsev Academy of Medical Education

    Saint Petersburg, Russian Federation, Russia

  • Zhordania and Khomasuridze Institute of Reproductology

    Tbilisi, Georgia, 0112, Georgia

More trials for these conditions

Other studies related to the condition(s) this trial covers.